Revenue Recognition (Tables)

9 Months Ended

Sep. 30, 2019

Revenue From Contract With Customer [Abstract]

Schedule of Company's Revenue for Reportable Segment by Country Based on Locations of Customer

Disaggregation of revenue

The following represents the Company’s revenue for its reportable segment by country, based on the locations of the customer.

	For the Three Months Ended September 30, 2019
	(In Thousands)
	Oncology Innovation Platform		Global Supply Chain Platform		Commercial Platform		Consolidated Total
United States	$	—	$	3,618	$	12,006	$	15,624
India		—		1,684		—		1,684
China		115		448		—		563
South Korea		—		513		—		513
Austria		—		476		—		476
Germany		—		398		—		398
Other foreign countries		—		106		—		106
Total revenue	$	115	$	7,243	$	12,006	$	19,364

	For the Three Months Ended September 30, 2018
	(In Thousands)
	Oncology Innovation Platform		Global Supply Chain Platform		Commercial Platform		Consolidated Total
United States	$	—	$	2,244	$	7,315	$	9,559
Spain		5,000		—		—		5,000
Austria		—		2,227		—		2,227
China		117		189		—		306
India		—		259		—		259
Other foreign countries		—		1,077		—		1,077
Total revenue	$	5,117	$	5,996	$	7,315	$	18,428

	For the Nine Months Ended September 30, 2019
	(In Thousands)
	Oncology Innovation Platform		Global Supply Chain Platform		Commercial Platform		Consolidated Total
United States	$	—	$	15,840	$	38,279	$	54,119
Austria		—		4,423		—		4,423
India		—		3,066		—		3,066
China		421		1,416		—		1,837
United Kingdom		—		1,023		—		1,023
Germany		—		602		—		602
South Korea		—		513		—		513
Other foreign countries		—		1,285		—		1,285
Total revenue	$	421	$	28,168	$	38,279	$	66,868

	For the Nine Months Ended September 30, 2018
	(In Thousands)
	Oncology Innovation Platform		Global Supply Chain Platform		Commercial Platform		Consolidated Total
Spain	$	30,000	$	—	$	—	$	30,000
United States		—		4,399		23,006		27,405
Austria		—		5,102		—		5,102
China		532		1,385		—		1,917
India		—		1,701		—		1,701
Other foreign countries		—		1,704		—		1,704
Total revenue	$	30,532	$	14,291	$	23,006	$	67,829

Summary of Receivables and Contract Liabilities From Contracts with Customers

The following table provides information about receivables and contract liabilities from contracts with customers. The Company has not recorded any contract assets from contracts with customers.

	September 30, 2019			December 31, 2018
	(In Thousands)
Accounts receivable, gross	$	37,210		$	26,061
Chargebacks and other deductions		(19,909	)		(13,101	)
Allowance for doubtful accounts		(133	)		(9	)
Accounts receivable, net	$	17,168		$	12,951
Deferred revenue		20,071			190
Total contract liabilities	$	20,071		$	190

Summary of Accounts Receivable Balances by Reportable Segments

The following tables illustrate accounts receivable balances by reportable segments.

	September 30, 2019
	(In Thousands)
	Oncology Innovation Platform		Global Supply Chain Platform			Commercial Platform			Consolidated Total
Accounts receivable, gross	$	—	$	4,888		$	32,322		$	37,210
Allowance for doubtful accounts, chargebacks, and    other deductions		—		(120	)		(19,922	)		(20,042	)
Accounts receivable, net	$	—	$	4,768		$	12,400		$	17,168

	December 31, 2018
	(In Thousands)
	Oncology Innovation Platform		Global Supply Chain Platform			Commercial Platform			Consolidated Total
Accounts receivable, gross	$	—	$	7,814		$	18,247		$	26,061
Allowance for doubtful accounts, chargebacks, and    other deductions		—		(9	)		(13,101	)		(13,110	)
Accounts receivable, net	$	—	$	7,805		$	5,146		$	12,951